期刊文献+

TFPI-2对胰腺癌细胞增殖及血管新生的抑制作用 被引量:2

Inhibitory effect of tissue factor pathway inhibitor 2 on cell proliferation of pancreatic carcinoma cells and tumor angiogenesis
下载PDF
导出
摘要 目的探讨胰腺癌中组织因子途径抑制物-2(TFPI-2)的表达及作用。方法采用免疫组织化学方法检测41例胰腺癌组织中TFPI-2,Ki-67和VEGF的表达及CD34单克隆抗体标记的微血管密度(MVD)。结果Ⅰ,Ⅱ期胰腺癌TFPI-2阳性表达率(17/26)高于Ⅲ,Ⅳ期(2/15),高分化癌(12/19)高于中、低分化(7/22)(均P<0.05);Ⅰ,Ⅱ期癌细胞增殖指数(PI)(24.45±6.19)低于Ⅲ,Ⅳ期癌(30.84±6.70),高分化癌(24.42±6.29)低于中、低分化癌(28.84±7.12),(均为P<0.05);Ⅰ,Ⅱ期癌VEGF的阳性表达率(16/26)低于Ⅲ,Ⅳ期癌(14/15),高分化癌(11/19)低于中、低分化癌(19/22)(均P<0.05);Ⅰ,Ⅱ期癌MVD值(26.92±1.06)低于Ⅲ,Ⅳ期癌(28.47±2.23),高分化癌(19.00±2.58)低于中、低分化癌(16.68±1.79)(均P<0.05)。胰腺癌组织中TFPI-2的表达与Ki-67和VEGF的表达呈负相关(r=-0.62,P<0.05;r=-0.54,P<0.05),MVD与TFPI-2表达亦有相关。结论TFPI-2表达能够抑制胰腺癌细胞增殖,并通过下调VEGF的表达抑制肿瘤新生血管的形成,这可能是其抑制胰腺癌的生长、转移的重要机制。 Objective To explore the expression and action of tissue factor pathway inhibitor 2 ( TFPI-2 ) in pancreatic carcinoma ( PC ). Methods Tissue specimens from 41 pancreatic cancers were used to detect the expression of TFPI-2, Ki-67, VEGF and MVD tagged with CD34 by immunohistochemistry. Results The positive expression of TFPI-2 in stage Ⅰ and ⅡPC (17/26) was higher than that in stage Ⅲand Ⅳ(2/15) PC. The positive expression of TFPI-2 in well-differentiated PC ( 12/19 ) was also higher than that in moderateand poorly-differentiated PC (7/22) ( P 〈 0.05 ) . The cell proliferation index in stage Ⅰ, Ⅱ(24.45 ±6. 19) and well-differentiated PC (24.42 ±6. 29) was lower than that in stage III , IV (30.84±6. 70) and moderate-, and poorly-differentiated PC (28. 84 ±7. 12) (P 〈 0. 05). The positive expression of VEGF in stage Ⅰand ⅡPC ( 16/26 ) was higher than that in stage Ⅲand Ⅳ(14/15). The positive expression of VEGF in well-differentiated PC (11/19) was also higher than that in moderate- and poorly-differentiated PC (19/22) (P 〈 0.05) . The value of MVD in stage Ⅰ, Ⅱ(26.92 ±1. 06 ) and well-differentiated PC ( 19. 00 ±2. 58 ) was lower than that in stage of Ⅲ, Ⅳ(28.47±2.23) and moderate- and poorly-differentiated PC (16. 68 ±1. 79), (P 〈 0. 05 ). The expression of TFPI-2, Ki-67 and VEGF was negatively correlated. The MVD was related to the expression of TFPI-2. Conclusions TFPI-2 can inhibit cell proliferation of PC, and by reducing the expression of VEGF can inhibit the angiogenesis of new vessels in PC, which may play an important part in inhibitory effect on invasion and metastasis of PC.
出处 《中国普通外科杂志》 CAS CSCD 2007年第10期959-961,共3页 China Journal of General Surgery
基金 安徽省自然科学基金资助项目(050430702)
关键词 胰腺肿瘤 新生血管化 病理性 组织因子途径抑制物2 Pancreatic Neoplasms Neovascularization, Pathologic Tissue Factor Pathway Inhibitor 2
  • 相关文献

参考文献9

  • 1Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer [J]. Cancer, 1997, 80(9) :1803 - 1804. 被引量:1
  • 2Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer[J]. Cancer Res, 1995, 55(18) :3964 - 3968. 被引量:1
  • 3Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1) :9-19. 被引量:1
  • 4Kong D, Ma D, Bai H, et al. Expression and characterization of the first kunitz domain of human tissue factor pathway inhibitor-2 [J]. Biochem Biophys Res Commun, 2004, 324(4) :1179- 1185. 被引量:1
  • 5Yanamandra N, Kondraganti S, Gondi CS, et al. Recombinant adeno-associated virus ( rAAV ) expressing TFP1-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line [J]. Int J Cancer, 2005, 115 (6): 998 - 1005. 被引量:1
  • 6Chand HS, Du X, Ma D, et al. The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice [J]. Blood, 2004, 103(3) :1069 -1077. 被引量:1
  • 7Kondraganti S, Gondi CS, Gujrati M, et al. Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line[J]. Int J Oncol, 2006, 29(1) :25 -32. 被引量:1
  • 8Kayaseleuk F, Zorludemir S, Gumurdulu D, et al. PCNA and Ki-67 in central nervous system tumors : correlation with the histological and grade [J]. Neurooneology, 2002, 57 (2) :115-121. 被引量:1
  • 9邵成浩,胡先贵,唐岩,刘瑞,曹贵松.胰腺癌的血管生成及临床意义[J].中国普通外科杂志,2003,12(2):125-127. 被引量:7

二级参考文献9

  • 1Cianchi F, Palomba A, Messerini L,et al. Tumor angiogenesis in lymph node-negative rectal cancer: correlation with clinicopathological parameters and prognosis[J]. Ann Surg Oncol, 2002,9(1): 20-26. 被引量:1
  • 2Chen CN, Cheng YM, Lin MT,et al. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer[J]. Ann Surg, 2002,235(4): 512-518. 被引量:1
  • 3Veidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma[J]. J Natl Cancer Inst, 1992, 84(24): 1875-1887. 被引量:1
  • 4van Hinsbergh VW, Collen A, Koolwijk P. Angiogenesis and anti-angiogenesis: perspectives for the treatment of solid tumors[J]. Ann Oncol,1999,10 (Suppl 4):60-63. 被引量:1
  • 5Brat DJ, Kaur B, Van Meir EG. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors[J]. Front Biosci, 2003,8(1):100-116. 被引量:1
  • 6Sipos B, Weber D, Ungefroren H,et al. Vascular endothelial growth factor mediated angiogenic potentialof pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study[J]. Int J Cancer, 2002,102(6): 592-600. 被引量:1
  • 7Ikeda N, Adachi M, Taki T,et al. Prognostic significance of angiogenesis in human pancreatic cancer[J]. Br J Cancer,1999,79(9-10): 1553-1563. 被引量:1
  • 8Stipa F, Lucandri G, Limiti MR,et al. Angiogenesis as a prognostic indicator in pancreatic ductal adenocarcinoma[J]. Anticancer Res, 2002,22(1A): 445-449. 被引量:1
  • 9马大烈,郑青渝,李全华,黄玲,魏建丽.微波EnVision免疫组织化学技术及其应用[J].中华病理学杂志,1998,27(2):153-154. 被引量:37

共引文献6

同被引文献24

  • 1Shao-Hua Peng,Hong Deng,Jian-Feng Yang,Ping-Ping Xie,Cheng Li,Hao Li,De-Yun Feng.Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues[J].World Journal of Gastroenterology,2005,11(41):6521-6524. 被引量:14
  • 2侯仁好,初晓艺,刘希双.胃管状腺癌组织中Fos和Jun蛋白表达及临床意义[J].中华肿瘤防治杂志,2006,13(24):1860-1862. 被引量:5
  • 3刘娟,张宏伟.TFPI-2与恶性肿瘤关系的研究进展[J].中国临床医学,2007,14(3):448-450. 被引量:2
  • 4Hube F,Reverdiau P,Ioehmann S, et al. Computer model of the in-teraction of human TFPI - 2 Kunitz - ty serine protease inhibitorwith human plasmin [J]. Thrombosis Research. 2003,111:597-198. 被引量:1
  • 5YanamandraN, KondragantiS, GondiCS, et al. Recombinant ade-noassociated virus (rA AV) expressing TFPI -2 inhibits invasion,angiogenesis and tumor growth in a human glioblastoma cell line[J]. Cancer, 2005,115 (6) : 998 -1005. 被引量:1
  • 6Kondraganti S, Gondi CS, Gujrati M , et al. Restoration of tissuefactor path way inhibitor inhibits invasion and tumor growth in vitroand in vivo in a malignant meni - ngioma cell line [J]. Int J On-col, 2006, 29(1):25-32. 被引量:1
  • 7Xu Z, Maiti D,Kisiel W,et al. Tissue factor pathway inhibitor - 2is upregulated by vascu - lar endothelial growth factor and sup-presses growth factor - induced proliferation of endothelial cells[J]. Arterioscler Thromb Vase Biol,2006,26 (12) :2819 -2825. 被引量:1
  • 8Baker AH, Edwards DR, Murphy G, et al. Metalloproteinase in-hibitors :boilogicalacti - ons and therapeutic opportunities [J].Cell Sci, 2002,115 (19): 3719 -3727. 被引量:1
  • 9ChandHS, DuX, MaD. et al. The effect of human tissue factorpathway inhibitor -2 on the growth and metastasis of fibrosarcomatumors in athymic mice [J]. Blood, 2004,103(3) :1069 - 1077. 被引量:1
  • 10PeerschkeEI, PetrovanRJ, GhebrehiwetB, et al. Tissue factorpathway inhibittor -2( TFPI -2) recognizes the complement andkininogen binding protein gClqR/p33 (gCl qR) : implications forvascular inflammation [J]. Thromb Haemost, 2004, 92(4) : 811-819. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部